🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China flag China · Delayed Price · Currency is CNY
25.67
-1.60 (-5.87%)
At close: Nov 20, 2026

Wuhan Healthgen Biotechnology Company Description

Wuhan Healthgen Biotechnology Corp. engages in the research and development of molecular pharmaceuticals in China.

The company offers recombinant human serum albumin, proteins for cosmetics ingredients, and other recombinant proteins.

It also provides recombinant growth factors, such as recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, recombinant human insulin-like growth factor-1 LR3, recombinant human vascular endothelial, recombinant human keratinocyte growth factor, recombinant human fibronectin, recombinant human α-1 antitrypsin, recombinant human lactoferrin, recombinant human epidermal growth factor, and recombinant human fibronectin.

In addition, it provides recombinant protein expression, purification process development, and detection methodology services.

The company was founded in 2006 and is based in Wuhan, China.

Wuhan Healthgen Biotechnology Corp.
CountryChina
Founded2006
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees278
CEODaichang Yang

Contact Details

Address:
268 Shendun 5th Road
Wuhan, 430020
China
Phone86 27 5940 3931
Websiteoryzogen.com

Stock Details

Ticker Symbol688765
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100007D17
SIC Code2836

Key Executives

NamePosition
Daichang YangChairman and GM
Dan YuChief Financial Officer
Zhi Jie QinChief Medical Officer
Xue LiSecretary of the Board
Bo ShiDeputy General Manager
Liangliang DongSenior Director of Scientific Research Projects
Jiquan OuDirector of Scientific Research Projects
Nili WangSenior Manager of Scientific Research Projects